Brave is a network of surgeons, volunteers and industry leaders challenging the system by guiding all breast cancer survivors through the complex world of breast reconstructive options and fearlessly advocating for access to their choice of care.

GC Aesthetics is a disruptive innovator in global breast aesthetics. As a member of the Executive Management team, I am challenged at spearheading the global commercial sales effort. Focused on maximizing productivity and effectiveness through multiple distribution channels. Emphasizing the collaborative relationships between, GC Aesthetics, surgeons and women around the world, to advance the specialty of Plastic Surgery focused on patient safety, women’s health and clinical data.• Led Global Commercial efforts with Direct Sales organization in 10 countries and Partner/Distributor in 70 countries • Led Commercial efforts in 10 Direct Sales organizations globally• Led Commercial efforts in 70 Partner/Distributors globally• 2024 Revenue Projection of $70.9M • 20% average Year over Year Growth with 15 Consecutive Quarters of Double-Digit Growth• 6 unique product launch within the past 36 months• 4 consecutive years of 20% Top Line Revenue Growth• 1st Breast Implant to receive MDR within the European Union

I am honored to lead the IDE and PMA efforts for GC Aesthetics within the United States. Our goal is to introduce this innovative, safe, efficacious and disruptive technology to the United States market. A technology, that has been available to surgeons and patients around the world for over 30 years. More than 2.5 million women in 70 countries have trusted GCA products, which is supported by 10-year clinical data.I will leverage my 20+ years in the Aesthetic/Reconstructive space to facilitate this process.

My responsibilities include the management of 40 independent sales consultants, while assisting in the execution of the corporate vision.

Integral part of the Executive Management team which negotiated the acquisition of Keller Medical by Allergan Corporation. Responsibilities include the management of 40 independent sales consultants, while developing marketing strategies and future market development. Annual sales growth combined with cost containment was a primary component for the companies acquisition by Allergan for greater than 10 times domestic sales. • 2017: Increased Domestic Sales Revenue by 20.13% year over year• 2017: Increased Domestic New Customers base 11%• 2016: Increased Domestic Sales Revenue by 31.06% year over year• 2016 Increase Domestic New Customers base 16%

Responsibilities include the sales, training and motivation of 31 independent sales representatives, while building brand loyalty and constantly exploring new innovative technology to compliment our existing product portfolio.2014: Increase Domestic Sales Revenue by 15% year over year

My responsibilities include but are not limited to the vertical integration of new products to the Sientra product portfolio.

As an original member of the Sientra management team, I worked in conjunction with the Clinical and Regulatory teams to achieve F.D.A. of the first new breast implant company to gain access to the US mark in over 20 years and later toward the eventual IPO . This innovative and disruptive organization, accomplished the Herculean task of breaking up the twenty year duopoly between Allergan and Mentor. My key areas of responsibilities include, but are not confined to the management of 10 Plastic Surgery Consultants, marketing the disruptive 5th generation of Silimed Breast Implants and Tissue Expanders. Additional responsibilities include the education and training of new surgeons and residence on the proper use of the entire Silimed product portfolio.

Responsibilities include, but are not limited to, the sales and marketing of saline and silicone breast implants within a defined geographic region. Additional responsibilities include the education and training of new representatives, surgeons and residents within my region and territory.• 2005 The Excellence Award• 2004-2005 Customer Care Council• 2004 Presidents Club• 2003 The Excellence Award• 2003 Presidents Club• 2002 Inaugural Crystal Eagle Award for Personal Commitment and Leadership• 2002 Presidents Club• 2001 Southern Region Highest Percent over Quota Award• 2001 Presidents Club • 2001-2004 Regional Breast Trainer• 2000 Presidents ClubOver 5,000 hours of Operating Room experience

The sales and marketing of the LySonix 2000 Ultrasonic Liposuction machine to Plastic Surgeons across the southeastern United States.Over 3,000 hours of Operating Room experience.